drugset / Trial / NCT06871761
A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy and safety of HR17031 injection and insulin glargine, including the changes of efficacy indicators such as HbA1c, fasting blood glucose, body weight and safety indicators such as adverse events and hypoglycemic events.
Timeline
- Start
- 2024-05-08
- Primary completion
- 2025-05-13
- Completion
- 2025-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR17031 | Unknown | — | — |
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |
Indications
No indication recorded.